Research ArticleOriginal Research

Physician Perspectives on Mammography Screening for Average-Risk Women: “Like a Double-Edged Sword”

Sophia Siedlikowski, Roland Grad, Gillian Bartlett and Carolyn Ells
The Journal of the American Board of Family Medicine November 2020, 33 (6) 871-884; DOI: https://doi.org/10.3122/jabfm.2020.06.200102

References

  1. 1.↵
    1. Myers ER,
    2. Moorman P,
    3. Gierisch JM,
    4. et al
    . Benefits and harms of breast cancer screening: a systematic review. JAMA 2015;314:1615–34.
    OpenUrlCrossRefPubMed
  2. 2.↵
    The Canadian Partnership Against Cancer. Cancer screening programs across Canada. 2018. Available from: https://www.partnershipagainstcancer.ca/topics/breast-cancer-screening-environmental-scan-2018/.
  3. 3.↵
    1. Plutynski A
    . Ethical issues in cancer screening and prevention. J Med Philos 2012;37:310–23.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Welch HG,
    2. Passow HJ
    . Quantifying the benefits and harms of screening mammography. JAMA Intern Med 2014;174:448–54.
    OpenUrl
  5. 5.↵
    1. Welch HG,
    2. Black WC
    . Overdiagnosis in cancer. JNCI 2010;102:605–13.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Biller-Andorno N,
    2. Jüni P
    . Abolishing mammography screening programs? a view from the Swiss Medical Board. N Engl J Med 2014;370:1965–7.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Barratt A,
    2. Jørgensen K,
    3. Autier P
    . Reform of the national screening mammography program in france. JAMA Intern Med 2018;178:177–8.
    OpenUrl
  8. 8.↵
    1. Andersson I,
    2. Sigfusson B
    . Screening for breast cancer in Malmö: a randomized trial. Breast Cancer. Recent Results Cancer Res 1987;105:62–6.
    OpenUrlPubMed
  9. 9.↵
    1. Nyström L,
    2. Bjurstam N,
    3. Jonsson H,
    4. Zackrisson S,
    5. Frisell J
    . Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg. J Med Screen 2017;24:34–42.
    OpenUrl
  10. 10.↵
    1. Gøtzsche PC,
    2. Jørgensen KJ
    . Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;2013:CD001877.
    OpenUrl
  11. 11.↵
    1. Juth N,
    2. Munthe C
    . The ethics of screening in health care and medicine: serving society or serving the patient? Berlin, Germany: Springer Science & Business Media; 2011.
  12. 12.↵
    The Independent Panel on UK Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778–86.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Klarenbach S,
    2. Sims-Jones N,
    3. Lewin G,
    4. et al
    . Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer. Can Med Assoc J 2018;190:E1441–E1451.
    OpenUrlFREE Full Text
  14. 14.↵
    1. Hoffmann TC,
    2. Del Mar C
    . Clinicians’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med 2017;177:407–19.
    OpenUrl
  15. 15.↵
    1. Wegwarth O,
    2. Schwartz LM,
    3. Woloshin S,
    4. Gaissmaier W,
    5. Gigerenzer G
    . Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med 2012;156:340–9.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    The Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40–74 years. Can Med Assoc J 2011;183:1991–2001.
    OpenUrlFREE Full Text
  17. 17.↵
    The Canadian Institute for Health Information. Unnecessary Care in Canada. 2017. Available from: https://www.cihi.ca/sites/default/files/document/choosing-wisely-baseline-report-en-web.pdf.
  18. 18.↵
    1. Moynihan R,
    2. Doust J,
    3. Henry D
    . Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502.
    OpenUrlFREE Full Text
  19. 19.↵
    1. Rogers WA,
    2. Mintzker Y
    . Casting the net too wide on overdiagnosis: benefits, burdens and non-harmful disease. J Med Ethics 2016;42:717–103715.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Morris E,
    2. Feig SA,
    3. Drexler M,
    4. Lehman C
    . Implications of overdiagnosis: impact on screening mammography practices. Pop Health Manag 2015;18:S3–S11.
    OpenUrl
  21. 21.↵
    1. Barratt A
    . Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality. BMJ 2015;350:h867–h867.
    OpenUrlFREE Full Text
  22. 22.↵
    1. Baines CJ,
    2. To T,
    3. Miller AB
    . Revised estimates of overdiagnosis from the Canadian National Breast Screening Study. Prev Med 2016;90:66–71.
    OpenUrl
  23. 23.↵
    1. De Gelder R,
    2. Heijnsdijk EA,
    3. Van Ravesteyn NT,
    4. Fracheboud J,
    5. Draisma G,
    6. De Koning HJ
    . Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011;33:111–21.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Coldman A
    . Overdiagnosis of breast cancer associated with screening mammography. North American Association of Central Cancer Registries. 2014. Ottawa, Canada. Available from: https://www.naaccr.org/wp-content/uploads/2016/11/PLENARY-6-25-14NAACCR-2014-SES-Coldman.pdf.
  25. 25.↵
    1. Loeb S,
    2. Bjurlin MA,
    3. Nicholson J,
    4. et al
    . Overdiagnosis and overtreatment of prostate cancer. Eur Urol 2014;65:1046–55.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Cassel CK,
    2. Guest JA
    . Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA 2012;307:1801–2.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Ebell MH,
    2. Thai TN,
    3. Royalty KJ
    . Cancer screening recommendations: an international comparison of high income countries. Public Health Rev 2018;39:7.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Miller JW,
    2. Baldwin LM,
    3. Matthews B,
    4. et al
    . Physicians’ beliefs about effectiveness of cancer screening tests: a national survey of family physicians, general internists, and obstetrician-gynecologists. Prev Med 2014;69:37–42.
    OpenUrl
  29. 29.↵
    1. Meissner HI,
    2. Klabunde CN,
    3. Han PK,
    4. Benard VB,
    5. Breen N
    . Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer 2011;117:3101–11.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Scheel JR,
    2. Hippe DS,
    3. Chen LE,
    4. et al
    . Are physicians influenced by their own specialty society’s guidelines regarding mammography screening? An analysis of nationally representative data. Am J Roentgenol 2016;207:959–64.
    OpenUrl
  31. 31.↵
    1. Smith P,
    2. Hum S,
    3. Kakzanov VD,
    4. Giudice ME,
    5. Heisey R
    . Physicians’ attitudes and behaviour toward screening mammography in women 40 to 49 years of age. Can Fam Physician 2012;58:e508–e13.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Tudiver F,
    2. Guibert R,
    3. Haggerty J,
    4. et al
    . What influences family physicians’ cancer screening decisions when practice guidelines are unclear or conflicting? J Fam Pract 2002;51:760.
    OpenUrlPubMed
  33. 33.↵
    1. Haggerty J,
    2. Tudiver F,
    3. Brown JB,
    4. Herbert C,
    5. Ciampi A,
    6. Guibert R
    . Patients’ anxiety and expectations: how they influence family physicians’ decisions to order cancer screening tests. Can Fam Physician 2005;51:1658–9.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Chamot E,
    2. Charvet A,
    3. Perneger TV
    . Women’s preferences for doctor’s involvement in decisions about mammography screening. Med Decis Making 2004;24:379–85.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Grad R,
    2. Pluye P,
    3. Tang D,
    4. Shulha M,
    5. Slawson DC,
    6. Shaughnessy AF
    . Patient-Oriented Evidence that Matters (POEMs)™ suggest potential clinical topics for the Choosing Wisely™ campaign. J Am Board Fam Med 2015;28:184–9.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Grad RO,
    2. Tang DLP
    . POEMs reveal candidate clinical topics for the Choosing Wisely Campaign. Preventing Overdiagnosis Conference. Bethesda, MD, September 2015.
  37. 37.↵
    1. Grad RM,
    2. Pluye P,
    3. Mercer J,
    4. et al
    . Impact of research-based synopses delivered as daily e-mail: a prospective observational study. J Am Med Inform Assoc 2008;15:240–5.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Badran H,
    2. Pluye P,
    3. Grad R
    . When educational material is delivered: a mixed methods content validation study of the information assessment method. JMIR Med Educ 2017;3:e4.
    OpenUrl
  39. 39.↵
    1. Braun V,
    2. Clarke V
    . Using thematic analysis in psychology. Qualitative Res Psychol 2006;3:77–101.
    OpenUrlCrossRef
  40. 40.↵
    NVivo. NVivo qualitative data analysis Software; QSR International Pty Ltd. Version 11.4.1. 2016.
  41. 41.↵
    1. Pluye P,
    2. Grad R,
    3. Repchinsky C,
    4. et al
    . “Better-than-best” evidence? Using family physicians’ feedback for 2-way knowledge translation. Can Fam Physician 2014;60:415–7.
    OpenUrlFREE Full Text
  42. 42.
    1. Bleyer A,
    2. Welch HG
    . Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998–2005.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.
    1. Brodersen J,
    2. Siersma VD
    . Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013;11:106–15.
    OpenUrlAbstract/FREE Full Text
  44. 44.
    1. Miller AB,
    2. Wall C,
    3. Baines CJ,
    4. Sun P,
    5. To T,
    6. Narod SA
    . Twenty-five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Hersch J,
    2. Barratt A,
    3. Jansen J,
    4. et al
    . Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015;385:1642–52.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Cifu AS,
    2. Prasad VK
    . Medical debates and medical reversal. J Gen Intern Med 2015;30:1729–30.
    OpenUrl
  47. 47.↵
    Canadian Cancer Society. Being high risk for breast cancer. 2017. Available from: http://www.cbcf.org/ontario/AboutBreastHealth/Being-High-Risk/Pages/default.aspx.
  48. 48.↵
    1. Mehay R
    1. Hutchinson A,
    2. Slawson DC,
    3. Shaughnessy A,
    4. Underhill A
    . Information mastery decision-making and dealing with information overload. In: Mehay R, ed. The essential handbook for GP training and education. London, UK: Radcliffe Publishing; 2012.
  49. 49.↵
    1. Norris SL,
    2. Burda BU,
    3. Holmer HK,
    4. et al
    . Author’s specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol 2012;65:725–33.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Pathirana T,
    2. Clark J,
    3. Moynihan R
    . Mapping the drivers of overdiagnosis to potential solutions. BMJ 2017;358:j3879.
    OpenUrlFREE Full Text
  51. 51.↵
    1. Woloshin S,
    2. Schwartz LM
    . Numbers needed to decide. J Natl Cancer Inst 2009;101:1163–5.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    1. Prasad V,
    2. Cifu A
    . Medical reversal: why we must raise the bar before adopting new technologies. Yale J Biol Med 2011;84:471–8.
    OpenUrlPubMed
  53. 53.↵
    1. Sutton D,
    2. Qureshi R,
    3. Martin J
    . Evidence reversal–When New evidence contradicts current claims: a systematic overview review. J Clin Epidemiol 2018;94:76–84.
    OpenUrl
  54. 54.↵
    1. Raffle AE,
    2. Gray JM
    . Screening: evidence and practice. Oxford, UK: Oxford University Press; 2007.
  55. 55.↵
    1. Woolf SH,
    2. Krist AH,
    3. Lafata JE,
    4. et al
    . Engaging patients in decisions about cancer screening: exploring the decision journey through the use of a patient portal. Am J Prev Med 2018;54:237–47.
    OpenUrl
  56. 56.↵
    1. Bell NR,
    2. Grad R,
    3. Dickinson JA,
    4. et al
    . Better decision making in preventive health screening. Balancing benefits and harms. Can Fam Physician 2017;63:521–4.
    OpenUrlFREE Full Text
  57. 57.↵
    1. Grad R,
    2. Légaré F,
    3. Bell NR,
    4. et al
    . Shared decision making in preventive health care: what it is; what it is not. Can Fam Physician 2017;63:682–4.
    OpenUrlFREE Full Text
  58. 58.↵
    1. Blair L,
    2. Légaré F
    . Is shared decision making a utopian dream or an achievable goal? Patient 2015;8:471–6.
    OpenUrl
  59. 59.↵
    1. Nekhlyudov L,
    2. Ross-Degnan D,
    3. Fletcher SW
    . Beliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study. J Gen Intern Med 2003;18:182–9.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Tripp L,
    2. Abelson J
    . Supporting women at average risk to make informed decisions about mammography when there is no “right” answer: a qualitative citizen deliberation study. CMAJ Open 2019;7:E730–E737.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    1. DuBenske LL,
    2. Schrager S,
    3. McDowell H,
    4. Wilke LG,
    5. Trentham-Dietz A,
    6. Burnside ES
    . Mammography screening: gaps in patient’s and physician’s needs for shared decision making. Breast J 2017;23:210–4.
    OpenUrl
  62. 62.↵
    1. Stacey D,
    2. Légaré F,
    3. Lewis K,
    4. et al
    . Decision aids for people facing health treatment or screening decisions. The Cochrane Library 2017;4:CD001431.
    OpenUrl
  63. 63.↵
    1. Siedlikowski S,
    2. Ells C,
    3. Bartlett G
    . Scrutinizing screening: a critical interpretive review of primary care provider perspectives on mammography decision-making with average-risk women. Pub Health Rev 2018;39:15 Dec 1.
    OpenUrl
  64. 64.↵
    1. Keating NL,
    2. Pace LE
    . Breast cancer screening in 2018: time for shared decision making. JAMA 2018;319:1814–5.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords